Alcon AG | ALC - Passivo Circulante





Passivo Circulante Alterar Data
AstraZeneca USD 31.55B 1.02B 2026-06
Bayer EUR 32.27B 1.19B 2026-06
Essilor EUR 12.64B 490M 2026-06
Fresenius EUR 9.07B 468M 2026-06
Fresenius Medical Care EUR 7.18B 448.03M 2026-06
GlaxoSmithKline GBP 21.53B 895M 2026-06
GRIFOLS EUR 2.24B 112M 2026-06
Lonza CHF 3.57B 421M 2025-12
Merck EUR 8.12B 1.22B 2026-06
Novartis USD 31.75B 374M 2026-06
Philips EUR 7.42B 8M 2026-06
Roche Holding CHF 28.85B 846M 2026-06
Sanofi EUR 31.93B 1.92B 2026-06
Smith & Nephew USD 2.05B 510M 2026-06
Sonova Holding CHF 1.5B 303M 2025-06
UCB EUR 4.4B 470M 2025-12